approval
saveIBANDRONATE SODIUM — FDA approval
community read0 votes
Sponsor: APOTEX INC. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 244d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 244d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 244d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 244d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 244d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 244d ago
- approvalIBANDRONATE SODIUM — FDA approvalFeb 3, 2026 · 244d ago
- approvalIBANDRONATE SODIUM — FDA approvalJul 25, 2025 · 437d ago
same company · ±60 days · 6
- approvalIBANDRONATE SODIUM: IBANDRONATE SODIUM — FDA approvalFeb 3, 2026
- approvalIBANDRONATE SODIUM: IBANDRONATE SODIUM — FDA approvalFeb 3, 2026
- approvalDificid: FIDAXOMICIN — FDA approvalFeb 2, 2026
- approvalPREGABALIN: PREGABALIN — FDA approvalFeb 2, 2026
- approvalHYDROCORTISONE SODIUM SUCCINATE: HYDROCORTISONE SODIUM SUCCINATE — FDA approvalFeb 5, 2026
- approvalemtricitabine: EMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE (EMTRICITABINE) — FDA approvalJan 30, 2026
comments(0)
5-min edit window · permanent after that